Table 2 Characteristics of hospitals and patients participating in the CIN audit and feedback intervention trial
Characteristics | Enhanced feedback | Standard feedback | Total |
|---|---|---|---|
Cluster level | |||
 No. of hospitals, n/N | 6/6 | 6/6 | 12/12 |
 No. of hospitals with > 1 pediatrician*, n/N | 2/6 | 1/6 | 3/12 |
 No. of hospitals in malaria-endemic regions, n/N | 3/6 | 2/6 | 5/12 |
 No. of hospitals with > 40 pediatric beds, n/N | 2/6 | 2/6 | 4/12 |
Individual level | |||
 Pneumonia admissions | 1087 | 1212 | 2299 |
 Median age in months, (IQR) | 12 (7–17) | 14 (8–18) | 13 (8–24) |
 Males, n/N (%) | 604/1086 (55.6%) | 661/1200 (55.1%) | 1265/2286 (55.3%) |
 Duration of illness in days, median (IQR) | 3 (2–5) | 3 (2–5) | 3 (2–5) |
 Referred to hospital, n/N (%) | 101/860 (11.7%) | 179/724 (17.4%) | 280/1884 (14.9%) |
 Clinical findings during admission documented using a structured admission record form**, n/N (%) | 1069/1083 (98.7%) | 1199/1211 (99%) | 2268/2294 (98.9%) |
 Wheezing present during admission, n/N (%) | 83/1084 (7.7%) | 112/1203 (9.3%) | 195/2287(8.5%) |
 Comorbid diagnosis present at admission***, n/N (%) | 692/1027 (63.7%) | 827/1212 (68.2%) | 1519/2299(66.1%) |
 Mid-upper-arm-circumference, median (IQR) | 14 (13–15) | 14 (13–15) | 14(13–15) |
 Length of hospital stay, median (IQR) | 2 (1–5) | 3 (2–6) | 3 (1–5) |
 Died, n/N (%) | 22/1087 (2.0%) | 37/1212 (3.1%) | 59/2299 (2.6%) |